Welcome

Glasgow ECMC aims to translate findings from laboratory programs and into clinical studies. In particular, the development of novel agents and using biological markers to optimise, target and individualise treatment. The Centre has an active early phase (phase I/II) clinical trial programme in both solid tumours and haematological malignancies.